Document Detail


Role of cysteine in corneal wound healing after photorefractive keratectomy.
MedLine Citation:
PMID:  19122468     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To evaluate the efficacy of cysteine oral supplements in corneal wound healing after photorefractive keratectomy (PRK). METHODS: A total of 200 eyes (100 patients) underwent PRK. We divided patients into 2 groups; each group was composed of 50 patients (100 eyes). Group 1 patients were assigned to use oral L-cysteine, with a daily dose of 200 mg (100-mg pills to be taken twice a day) for a duration of 14 days, starting from the week preceding the operation; the patients in group 2 were used as a control, and received the oral supplementation of 40-mg placebo pills to be taken twice a day for a duration of 14 days, starting from the week preceding the operation. RESULTS: All the eyes of patients treated with cysteine oral supplements showed shorter times to re-epithelization than the eyes of the control group. The mean time of corneal wound healing observed in group 1 was 102 +/- 15 h, compared to an average of 159 +/- 9 h in group 2. CONCLUSION: Our research showed that oral cysteine supplementation, in a daily dose of 200 mg, reduces mean corneal wound healing time in patients after PRK.
Authors:
Alessandro Meduri; Pier Luigi Grenga; Lucia Scorolli; Piero Ceruti; Giuseppe Ferreri
Related Documents :
17943758 - Interventions for recurrent corneal erosions.
22201228 - Prognostic evaluation of electrocochleography in idiopathic sudden sensorineural hearin...
7663328 - Results of reshaping with the 193-nm excimer laser.
17531698 - Low-intensity ultraviolet a irradiation of the lens capsule to remove lens epithelial c...
24585488 - Late hdv rna relapse after peginterferon alfa-based therapy of chronic hepatitis delta.
2735338 - Sucralfate versus cimetidine in the treatment of reflux esophagitis in children.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2008-12-20
Journal Detail:
Title:  Ophthalmic research     Volume:  41     ISSN:  1423-0259     ISO Abbreviation:  Ophthalmic Res.     Publication Date:  2009  
Date Detail:
Created Date:  2009-01-28     Completed Date:  2009-03-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0267442     Medline TA:  Ophthalmic Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  76-82     Citation Subset:  IM    
Copyright Information:
(c) 2008 S. Karger AG, Basel.
Affiliation:
Department of Surgical Specialities, Ophthalmology Clinic, University of Messina, Messina, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Cysteine / administration & dosage*
Epithelium, Corneal / drug effects*
Female
Humans
Hyperopia / surgery
Lasers, Excimer*
Male
Myopia / surgery
Photorefractive Keratectomy*
Prospective Studies
Single-Blind Method
Time Factors
Wound Healing / drug effects*
Chemical
Reg. No./Substance:
52-90-4/Cysteine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of antimicrobial peptides at the ocular surface.
Next Document:  Correlation of cell cycle kinetics with p63 expression in human limbal epithelial cells expanded on ...